Llubinko Stojkovic

Title: The Innovative Contributions of Llubinko Stojkovic

Introduction

Llubinko Stojkovic is a notable inventor based in Basel, Switzerland. He has made significant strides in the field of medical innovations, particularly in the development of vaccines. His work focuses on addressing urinary tract infections, a common health issue affecting many individuals.

Latest Patents

Stojkovic holds a patent for a vaccine designed for the treatment of urinary tract infections. This vaccine is intended for both curative and prophylactic treatment in humans. It contains inactivated bacteria derived from cultures of 8 to 14 uropathogenic bacteria strains isolated from the urine of individuals suffering from urinary tract infections. The vaccine includes aluminum phosphate in an amount of 1.5-10 mg of AlPO.sub.4 per ml of solution. The bacteria species involved in this vaccine include E. coli, Klebsiella pneumoniae, Proteus mirabilis, Proteus morganii, and Streptococcus faecalis.

Career Highlights

Stojkovic is currently associated with Solco Basel AG, where he continues to contribute to innovative medical solutions. His expertise in vaccine development has positioned him as a key figure in the fight against urinary tract infections.

Collaborations

Throughout his career, Stojkovic has collaborated with talented professionals, including Vera Spasojevic and Rodmila Pavic. These collaborations have enhanced his research and development efforts, leading to impactful innovations in the medical field.

Conclusion

Llubinko Stojkovic's contributions to vaccine development highlight his commitment to improving healthcare solutions. His innovative approach to treating urinary tract infections showcases the importance of research and collaboration in the medical field.